Risvutatug rezetecan, CAS [[3042849-33-9]]

Produktübersicht

• Artikelname: Risvutatug rezetecan, CAS [[3042849-33-9]]
• Artikelnummer: MCE-HY-185279
• Hersteller Artikelnummer: HY-185279
• Alternativnummer: MCE-HY-185279-1MG, MCE-HY-185279-5MG, MCE-HY-185279-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: HS-20093, GSK5764227

Produktbeschreibung

Risvutatug rezetecan (HS-20093, GSK5764227) is a B7-H3-targeting antibody-drug conjugate (ADC). Risvutatug rezetecan binds to B7-H3 on tumor cells and delivers a topoisomerase I inhibitor payload via a tumor microenvironment-responsive cleavable linker. Risvutatug rezetecan is applicable for the research of extensive-stage small cell lung cancer and non-small cell lung cancer[1].

Produkteigenschaften

• CAS Nummer: [3042849-33-9]
• Target-Kategorie: Antibody-Drug Conjugates (ADCs),CD276/B7-H3

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: ADC Related